TSMR.F Stock Overview
Tsumura & Co. manufactures and sells pharmaceutical products worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
Tsumura & Co. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥25.86 |
| 52 Week High | JP¥25.86 |
| 52 Week Low | JP¥18.10 |
| Beta | 0.19 |
| 1 Month Change | 11.47% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -24.71% |
| 5 Year Change | n/a |
| Change since IPO | 34.34% |
Recent News & Updates
Recent updates
Shareholder Returns
| TSMR.F | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | -2.2% | -3.7% |
| 1Y | n/a | 11.6% | 20.5% |
Return vs Industry: Insufficient data to determine how TSMR.F performed against the US Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how TSMR.F performed against the US Market.
Price Volatility
| TSMR.F volatility | |
|---|---|
| TSMR.F Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.6% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: TSMR.F's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine TSMR.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1893 | 4,032 | Terukazu Kato | www.tsumura.co.jp |
Tsumura & Co. manufactures and sells pharmaceutical products worldwide. The company offers Kampo extract intermediates and granular Kampo formulations. It is involved in the procurement, selection and processing, and storage of raw material crude drugs and crude drug pieces for decoction; manufacture of Kampo powdered extracts and traditional Chinese medicines; and sale of pharmaceuticals and food products.
Tsumura & Co. Fundamentals Summary
| TSMR.F fundamental statistics | |
|---|---|
| Market cap | US$1.91b |
| Earnings (TTM) | US$108.61m |
| Revenue (TTM) | US$964.34m |
17.4x
P/E Ratio2.0x
P/S RatioIs TSMR.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TSMR.F income statement (TTM) | |
|---|---|
| Revenue | JP¥148.79b |
| Cost of Revenue | JP¥78.01b |
| Gross Profit | JP¥70.78b |
| Other Expenses | JP¥54.02b |
| Earnings | JP¥16.76b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 09, 2024
| Earnings per share (EPS) | 220.71 |
| Gross Margin | 47.57% |
| Net Profit Margin | 11.26% |
| Debt/Equity Ratio | 26.8% |
How did TSMR.F perform over the long term?
See historical performance and comparison